The Ovarian Reserve Panel II (HHD) is the ultimate in diagnostic innovation, offering an all-encompassing evaluation of ovarian function with unmatched accuracy and depth. Designed with state-of-the-art technology and novel approaches, this panel provides a detailed assessment of ovarian reserve and provides remarkably accurate light on possible reproductive hormone abnormalities or problems with fertility.

Fundamentally, the Ovarian Reserve Panel II (HHD) combines a wide range of distinct indicators and molecular targets to allow medical professionals to investigate the intricacies of ovarian physiology. With information ranging from hormone tests to anti-Müllerian hormone (AMH) concentrations and follicle-stimulating hormone (FSH) levels, this panel provides a comprehensive picture of ovarian health, making it easier to identify and treat reproductive dysfunction or decreased ovarian reserve early on.

Additionally, the HHD Ovarian Reserve Panel II